Loading clinical trials...
Loading clinical trials...
LymphBridge: Prospective Evaluation of the BioBridge Scaffold as an Adjunct to Lymph Node Transplant for Upper Extremity Lymphedema
Conditions
Interventions
BioBridge® Collagen Matrix
Vascularized Lymph Node Transfer (VLNT)
Locations
2
United States
The University of Chicago Biological Sciences Division/University of Chicago Medical Center
Chicago, Illinois, United States
MD Anderson
Houston, Texas, United States
Start Date
October 26, 2020
Primary Completion Date
October 30, 2025
Completion Date
December 30, 2025
Last Updated
March 11, 2025
NCT07425522
NCT06960213
NCT07308639
NCT07516964
NCT07449936
NCT07208799
Lead Sponsor
Fibralign Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions